Dicarboxylic Acids
Data on dicarboxylic acids discussed by researchers at University of Southampton, Southampton Health Technology Assessments Center
Published in Hepatitis Weekly, June 28th, 2010
New investigation results, 'Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection,' are detailed in a study published in Health Technology Assessment. According to a study from Southampton, the United Kingdom, "This paper presents a summary of the evidence review group (ERG) report into the clinical effectiveness and cost-effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B, in accordance with the licensed indication, based upon the evidence submission from Gilead to the National Institute for Health and Clinical Excellence (NICE) as part of the single technology appraisal process. The submitted clinical evidence included...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2010-06-28)
More Articles from Hepatitis Weekly
- Intercellular Signaling Peptides and Proteins
22nd Annual 'Milstein Awards' Will Recognize Seminal Achievements among Interferon and Cytokine Researchers - Chronic Hepatitis
A nutritional supplement for treating chronic hepatitis C: Viusid - Intramuscular Injections
Alkermes Announces Notification of Tentative FDA Advisory Committee Meeting to Review VIVITROL(R) for Opioid Dependence - Hepatitis
Better Clarity on Diagnosis Facilitates the Introduction of Novel Treatments in the Hepatitis C Therapeutics Market in Australia, Finds Frost & Sullivan - Antivirals
Data from J. Bitard and colleagues advance knowledge in antivirals - Organic Research
Data from K.M. Belyk and colleagues advance knowledge in organic research - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
